The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments (Q34686955)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q56427239)
(Q43131595)
(Q41198442)
(Q38800657)
(Q64224916)
(Q24182136)
(Q104696550)
(Q41433034)
(Q114406410)
(Q48491706)
(Q114406413)
(Q61115328)
(P275) (Q19125117)
(P304) 62
(P478) 12
(P577) Wednesday, March 2, 2011
(P921) (Q8277)
(Q1922379)
(P1433) (Q7840023)
(P1476) "The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments" (language: en)
(P2093) Michael A Scott
Charles Crawley
Xiao-Ling He
Karen Richardson
Kelly Barber
Daniel J Webber
Ming-Qing Du
Shi L Luan
Andrew W Michell
(P2860) (Q34564111)
(Q33419385)
(Q37253314)
(Q28299151)
(Q33381736)
(Q29617267)
(Q37010552)
(Q34581641)
(Q27861120)
(Q40317890)
(Q33628308)
(Q36479923)
(Q39034605)
(Q40428057)
(Q30755158)
(Q27860737)
(Q50767537)
(Q46499204)
(Q52003093)
(Q27864122)
(Q43910524)
(Q48233479)
(Q45869701)
(Q52722694)
(Q62601707)
(Q69930057)
(Q63894361)
(Q60815891)
(P6216) (Q50423863)
other details